These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2435453)

  • 1. The metabolism of dopamine in the blood of ruminant animals: formation of 3,4-dihydroxyphenylacetaldehyde.
    Sharman DF
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(1):151-5. PubMed ID: 2435453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
    Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ
    Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
    Jinsmaa Y; Florang VR; Rees JN; Anderson DG; Strack S; Doorn JA
    Chem Res Toxicol; 2009 May; 22(5):835-41. PubMed ID: 19388687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ethanol, acetaldehyde and disulfiram on the metabolism of biogenic aldehydes in isolated human blood cells and platelets.
    Helander A; Tottmar O
    Biochem Pharmacol; 1987 Nov; 36(22):3981-5. PubMed ID: 2446627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.
    Lamensdorf I; Eisenhofer G; Harvey-White J; Hayakawa Y; Kirk K; Kopin IJ
    J Neurosci Res; 2000 May; 60(4):552-8. PubMed ID: 10797558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
    Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
    Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of dopamine in the blood of ruminant animals: an enzyme system to metabolize dopamine released from the mast cells in these species?
    Sharman DF; Kelly MJ; Loncar-Stevanović H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 75(2):217-22. PubMed ID: 6194929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
    Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
    Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation.
    Legros H; Dingeval MG; Janin F; Costentin J; Bonnet JJ
    Neurotoxicology; 2004 Mar; 25(3):365-75. PubMed ID: 15019299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma.
    Helander A; Tottmar O
    Biochem Pharmacol; 1987 Apr; 36(7):1077-82. PubMed ID: 2436624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    Jinsmaa Y; Isonaka R; Sharabi Y; Goldstein DS
    J Pharmacol Exp Ther; 2020 Feb; 372(2):157-165. PubMed ID: 31744850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The catecholaldehyde hypothesis: where MAO fits in.
    Goldstein DS
    J Neural Transm (Vienna); 2020 Feb; 127(2):169-177. PubMed ID: 31807952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
    Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
    Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Transformations of 3,4-Dihydroxyphenylacetaldehyde Generate Potential Reactive Intermediates as Causative Agents for Its Neurotoxicity.
    Ito S; Tanaka H; Ojika M; Wakamatsu K; Sugumaran M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.
    Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
    J Pharmacol Exp Ther; 2016 Feb; 356(2):483-92. PubMed ID: 26574516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three types of stereospecificity and the kinetic deuterium isotope effect in the oxidative deamination of dopamine as catalyzed by different amine oxidases.
    Yu PH
    Biochem Cell Biol; 1988 Aug; 66(8):853-61. PubMed ID: 3143375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection.
    Mefford IN; Ward MM; Miles L; Taylor B; Chesney MA; Keegan DL; Barchas JD
    Life Sci; 1981 Feb; 28(5):477-83. PubMed ID: 7207029
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.
    Rees JN; Florang VR; Eckert LL; Doorn JA
    Chem Res Toxicol; 2009 Jul; 22(7):1256-63. PubMed ID: 19537779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)].
    Bonnet JJ; Legros H; Janin F; Dourmap N; Costentin J
    Ann Pharm Fr; 2004 Sep; 62(5):323-31. PubMed ID: 15314580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.